BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3036157)

  • 21. Interactions of calmodulin antagonists with calcium antagonists binding sites.
    Schaeffer P; Lugnier C; Stoclet JC
    Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.
    Epstein PM; Moraski S; Hachisu R
    Biochem J; 1987 Apr; 243(2):533-9. PubMed ID: 2820385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Full activation without calmodulin of calmodulin-dependent cyclic nucleotide phosphodiesterase by acidic glycosphingolipids: GM3, sialosylneolactotetraosylceramide and sulfatide.
    Higashi H; Yamagata T
    FEBS Lett; 1992 Dec; 314(1):53-7. PubMed ID: 1333416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new peptide (1150Da) selectively activates the calcium-calmodulin sensitive isoform of cyclic nucleotide phosphodiesterase from human myometrium.
    Leroy MJ; Dumler I; Lugnier C; Shushakova ND; Ferré F
    Biochem Biophys Res Commun; 1992 Apr; 184(2):700-5. PubMed ID: 1315529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of calmodulin and calcium antagonists with [3H]diltiazem and [3H]nitrendipine binding sites.
    Schaeffer P; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S102-3. PubMed ID: 2468847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calmodulin-activated phosphodiesterase from vertebrate smooth muscle.
    Head JF; Birnbaum RJ; Kaminer B
    Ann N Y Acad Sci; 1980; 356():33-5. PubMed ID: 6263152
    [No Abstract]   [Full Text] [Related]  

  • 27. The binding of the calcium channel blocker, bepridil, to calmodulin.
    Itoh H; Tanaka T; Mitani Y; Hidaka H
    Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophobic regions function in calmodulin-enzyme(s) interactions.
    Tanaka T; Hidaka H
    J Biol Chem; 1980 Dec; 255(23):11078-80. PubMed ID: 6254958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of troponin I on the Ca-binding properties of calmodulin and activation of cyclic nucleotide phosphodiesterase by Ca ions].
    Men'shikov MIu; Rybin VO; Tkachuk VA
    Dokl Akad Nauk SSSR; 1981; 258(5):1250-4. PubMed ID: 6266797
    [No Abstract]   [Full Text] [Related]  

  • 30. Ophiobolin A. A natural product inhibitor of calmodulin.
    Leung PC; Taylor WA; Wang JH; Tipton CL
    J Biol Chem; 1984 Mar; 259(5):2742-7. PubMed ID: 6321479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the 63-kDa subunit-containing calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
    Sharma RK; Zhang GY; Mooibroek MJ; Wang JH
    Adv Exp Med Biol; 1989; 255():397-408. PubMed ID: 2559602
    [No Abstract]   [Full Text] [Related]  

  • 32. [The peptide activator of cyclic nucleotide phosphodiesterases: its effect on muscle contractile activity].
    Shchelkovnikov SA; Starshinova LA; Garnovskaia MN; Artem'ev NO; Etingof RN
    Biull Eksp Biol Med; 1988 Dec; 106(12):648-50. PubMed ID: 2850035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic and regulatory properties of calmodulin-stimulated phosphodiesterase isozymes.
    Wu Z; Sharma RK; Wang JH
    Adv Second Messenger Phosphoprotein Res; 1992; 25():29-43. PubMed ID: 1313263
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
    Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
    Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics of cyclic nucleotide phosphodiesterase and calmodulin in the small intestinal mucosa of rabbits].
    Iurkov VA
    Biull Eksp Biol Med; 1981 Jul; 92(7):91-4. PubMed ID: 6271290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The presence of calmodulin in chemosensory structures, its purification and content].
    Ostretsova IB; Suvorov SA; Levko AV; Etingof RN
    Biokhimiia; 1984 May; 49(5):777-80. PubMed ID: 6331533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase.
    Hu ZY; Chen SL; Hao ZG; Huang WL; Peng SX
    Cell Signal; 1989; 1(2):181-5. PubMed ID: 2561985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-induced exposure of a hydrophobic surface on calmodulin.
    LaPorte DC; Wierman BM; Storm DR
    Biochemistry; 1980 Aug; 19(16):3814-9. PubMed ID: 6250577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular properties of cyclic nucleotide phosphodiesterase isozymes.
    Strada SJ; Kithas PA; Whalin ME; Thompson WJ
    Adv Exp Med Biol; 1989; 255():409-23. PubMed ID: 2559603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
    Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
    Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.